Skip to content

Effects of Dry Needling on Spinal Mobility and Trigger Points in Patients With Fibromyalgia Syndrome.

Effects of Dry Needling on Posture, Spinal Mobility and Trigger Points on Spinal Muscles in Patients With Fibromyalgia Syndrome.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02380807
Enrollment
66
Registered
2015-03-05
Start date
2015-03-31
Completion date
2015-07-31
Last updated
2016-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain, Fibromyalgia

Keywords

Paraspinal Muscles, Trigger Points, Randomized Controlled Trial, Mobility Limitation

Brief summary

This study evaluates the effect of Dry Needling on Spinal Mobility and Trigger Points in Patients with Fibromyalgia Syndrome.

Detailed description

Dry Needling is a skilled intervention that uses a thin filiform needle to penetrate the skin and stimulate underlying myofascial trigger points, muscular, and connective tissues for the management of neuromusculoskeletal pain and movement impairments. Dry needling (DN) is a technique used to treat dysfunctions in skeletal muscle, fascia, and connective tissue, and, diminish persistent peripheral nociceptive input, and reduce or restore impairments of body structure and function leading to improved activity and participation.

Interventions

DEVICEDry Needling

Dry needling is the use of either solid filiform needles or hollow-core hypodermic needles for therapy of muscle pain, sometimes also known as intramuscular stimulation (IMS). Although dry needling originally utilized only hypodermic needles due to the concern that solid filiform needles had neither the strength or tactile feedback that hypodermic needles provided and that the solid filiform needle could be deflected by dense contraction knots.

OTHERCross Tape Therapy

The tape consists of cross bands or strips mesh cross, nonelastic and without any medication, forming a grid-shaped patch. The cross tape will be applied on trigger points.

Sponsors

Universidad de Almeria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Fibromyalgia syndrome diagnosis. * Aged from 18 to 65 years. * No regular physical activity. * Limitation of usual activities due to pain on at least 1 day in the previous 30 days. * Agreement to attend evening therapy sessions.

Exclusion criteria

* Severe physical disability. * Comorbid conditions (eg, morbid obesity, inflammatory diseases, irritable bowel syndrome, interstitial cystitis). * Uncontrolled endocrine disorders (eg, hyperthyroidism or hypothyroidism, diabetes). * Malignancy. * Psychiatric. * Illnesses (eg, schizophrenia or substance abuse). * Medication usage other than as-needed analgesics (excluding long-term narcotics). * History of surgery. * History of whiplash injury. * Presence of a score \>9 points in the Beck Depression Inventory.

Design outcomes

Primary

MeasureTime frameDescription
Pain Intensityup to Four WeeksA 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain.

Secondary

MeasureTime frameDescription
Number of participants with Trigger Pointsup to Four WeeksDry Needly Therapy will be assesses in trigger points on trapezius muscle, supraspinatus muscle, infraspinatus muscle, latissimus dorsi, iliocostalis muscle, multifidus muscles, and quadratus lumbourum muscle.
Posture and Spinal Mobilityup to Four WeeksSpinal Mouse is a device that, combined with a computer program (PC), assesses the curvatures of the vertebral column without applying harmful radiation. Spinal Mouse checks: spine alignment, measuring segmental and global angles in the sagittal and frontal planes; posture and spinal mobility; and spine functions and performance.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026